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doi: 10.3121/cmr.2010.892 hronic kidney disease (CKD) is a major health problem. Patients with end stage renal disease (ESRD) are characterized by higher mortality rates than the general population. 1 Mortality from cardiovascular disease (CVD) is 10 to 20 times higher among patients treated with long-term hemodialysis or peritoneal dialysis than in the general U.S. population. 2 The burden of classic and novel cardiovascular (CV) risks in individuals with earlier-stage kidney dysfunction is understudied in the general population. 3 The majority of deaths are due to CVD in ESRD patients, and CVD is also a significant cause of morbidity and acute hospitalization in these patients. 4 As a result, a combination of complications of CKD and accelerated CVD in these patients results in high rates of death. Some traditional CV risk factors that are male gender, hypertension, diabetes mellitus, high low density (LDL)-cholesterol, low high density (HDL)-cholesterol, physical inactivity, high body mass index (BMI), and obesity.
These are evident in patients with or without renal disease. 5 
C
Metabolic Syndrome (MS) has been recognized as a possible risk factor for renal damage, and the increased prevalence of both MS and renal disease justifies the increasing interest within the nephrology community toward MS as another possible inducing cause of CKD, although the available evidence of a direct causal relationship between MS and development of renal disease is scanty so far. 6 Kurella et al 7 concluded that MS is a risk factor for the development of diabetes and CVD; however, no prospective studies have examined MS as a risk factor for CKD.
Recently, a few population-based studies have been published. [8] [9] [10] doi: 10.3121/cmr.2010.892
As a result, increasing number of patients with CKD either requiring renal replacement therapy or not, may suffer from concomitant cardiovascular events. Improvement of CV risk factors may enhance health quality of patients with CKD and decrease morbidity and mortality rates.
The aim of this study was to determine MS frequency and CV risk factor profiles of patients with varying degree of renal failure.
Methods
Data of the participants were collected from the Nephrology Department of Istanbul Goztepe The number, gender, and age of the patients according to their GFR groups are shown in Table 1 . 
Association between GFR stages and cardiovascular risk factors
Hypertensive patients constituted 86.4% of the study group, 27% of the patients were hyperlipidemic, and diabetic patients constituted 32.6% of total patients. Thirty-two (14.5%) patients were current smokers, and HDL-cholesterol was lower than 40 mg/dL in 86 (40%) was also no significant difference between GFR groups with regard to being diabetic, a current smoker, or having low HDL-cholesterol level (P > 0.05). The association between GFR groups and BMI was significant in GFR 60-89 ml⁄min per 1.73 m 2 group and other groups (P = 0.001).
In the GFR < 15 ml⁄min per 1.73 m 2 group, obesity was significantly lower than the other groups (P = 0.001) .
Participants with one and two CV risk factors were more likely to have lower GFR (Table 3) . As GFR increased, the total number of patients who had more CV risk factors increased. So, there was a positive correlation between increasing GFR and the number of CV risk factors (P = 0.004).
Association between GFR stages and Metabolic Syndrome
The number of the patients with waist circumference larger than 80 cm in women and 94 cm in men with GFR < 15 ml⁄min per 1.73 m 2 were less than the patients with other GFR stages (P < Triglyceride levels were significantly higher in the patients with GFR < 15 ml⁄min per 1.73 m 2 than in the patients in other GFR groups (P = 0.001) ( Table 4 ) .
The number of MS parameters was positively correlated with increasing GFR (Table 5 ) . This association was considered statistically significant (P = 0.003). Odds ratio of the risk factors were represented in Table 6 . Median number of CV risk factors and MS parameters increased with GFR (Table 7) .
Discussion
As GFR increases, the total number of the patients having more CV risk factors increases, and 14 who found no significant association between diastolic blood pressure and GFR. In our study population, patients who were on renal replacement therapy were more lean than the patients in the other groups, so this might influence our results on hypertension.
Approximately 33% (n=70) of the patients in our study had diabetes mellitus, while 24% had diabetic kidney disease (n=51 Approximately 14% of our patients were current smokers. In the CHOICE study, about 18% of the patients were current smokers on dialysis. 22 Smoking has been linked to progression of kidney disease and of CVD in patients with reduced GFRs . proportion of the participants with CKD among those with or without each component of MS.
They concluded that elevated blood pressure, serum triglyceride, and plasma glucose were significantly associated with increased prevalence of CKD. Low HDL-cholesterol and abdominal obesity were significantly associated with increased prevalence of CKD. The patients in this study were not classified according to their GFR stages. Patients with GFR< 15 ml⁄min per 1.73 m 2 were more malnourished than the patients in the other groups, so they had lower waist circumference and their fasting plasma glucose levels were lower than the patients with GFR < 30 ml⁄min per 1.73 m 2 . Diabetic patients were prone to hypoglycemia due to advanced renal failure.
We found that the number of CV risk factors and MS parameters increased with increasing GFR.
Subjects with one and two risk factors were especially more likely to have lower GFR level. Our patients were from the Nephrology Department, so patient distribution was in a homogenous manner according to their GFR stages. Because uremia is a major risk factor for accelerated and atherosclerotic CV complications, dialysis procedures through bioincompatibility constitute an additional risk factor. 26 Tonelli et al 20 reported that CVD was common in the predialysis population, and its prevalence increased with more severe kidney failure. However, that study population consisted of patients who had creatinine clearances of 75 ml/min per 1.73 m 2 or less but were not on dialysis therapy. Patients with GFR < 15 ml⁄min per 1.73 m 2 were less obese and had the lowest waist circumference, so there was not a strong association with other CV risk factors and MS parameters. Our data showed that patients were undertreated for their hypertension, high LDL-cholesterol, and diabetes (e.g HbA1c level was 8,4±3.0%) . show an association between hypertension and mortality in hemodialysis patients. Fleischmann et al 31 concluded that conventional risk factors over at least a two-year period did not readily account for the higher mortality of a group of predominatly African-American patients on hemodialysis. It is also claimed that greater fluid retention between two subsequent hemodialysis treatment sessions is associated with higher risk of all-cause and cardiovascular death. 32 Heart failure is the most common cause of early death in patients on dialysis. 33 So, ESRD patients do not die as often of myocardial infarctions, but rather from sudden cardiac death and congestive heart failure.
Conclusion
The results of this study indicate that the number of the CV risk factors and MS frequency increases with increasing GFR. High frequency of CV risk factors among these patients suggests that cardiovascular disease begins in earlier stages of renal failure; therefore, implementation of risk factor reduction strategies earlier and agressively in the course of renal failure may provide an opportunity to prevent CVD in CKD patients who also suffer from dialysis related risk factors. GFR: Glomerular filtration rate *Likelihood Ratio P = 0.003
